Developmental Hemostasis: The Evolution of our Coagulation System

Gianna M. Guzzardo, Katherine Regling

Research output: Contribution to journalArticlepeer-review


Developmental hemostasis describes the evolution of the coagulation system from the neonatal period through adulthood. Neonates have lower levels of coagulation factors and elevated screening levels at birth. These levels can be influenced by various circumstances including gestational age, labor effects, and clinical status. The most commonly used screening tests for coagulopathy are the prothrombin time, partial thromboplastin time, and fibrinogen level. These values can be difficult to interpret as every laboratory has its own age-specific reference ranges. An understanding of developmental hemostasis is important when evaluating, diagnosing, and treating clinical manifestations, including vitamin K deficiency, surgical needs, infections, inherited thrombophilias, and inherited bleeding disorders. The mainstay of treatment for bleeding or hemorrhage is platelet and fresh frozen plasma transfusions. For the treatment of thrombosis, unfractionated heparin and low-molecular-weight heparin are the 2 most commonly used anticoagulants in the neonatal setting.

Original languageEnglish
Pages (from-to)e82-e95
Issue number2
StatePublished - Feb 1 2022
Externally publishedYes


Dive into the research topics of 'Developmental Hemostasis: The Evolution of our Coagulation System'. Together they form a unique fingerprint.

Cite this